Deletions in the 13q14 locus in adult lymphoblastic leukemia : Rate of incidence and relevance

✍ Scribed by Ching-Yang Chung; Hagop Kantarjian; Mohammed Haidar; Petr Starostik; Taghi Manshouri; Cristi Gidel; Emil Freireich; Michael Keating; Maher Albitar

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 126 KB
• Volume: 88
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(20000315)88:6<1359::aid-cncr12>3.0.co;2-q

✦ Synopsis

A putative tumor suppressor gene involved in chronic lymphocytic leukemia (CLL) has been localized to the 13q14 locus. Microsatellite analysis was used to test whether this locus also is involved in acute lymphoblastic leukemia (ALL) and its prognostic relevance determined.

METHODS.

The authors analyzed 49 patients with adult ALL for deletions at the 13q14 locus using a battery of 6 microsatellite markers corresponding to this region (D13S260, STR257, D13S263, D13S153, D13S319, and AFMa301wb5).

RESULTS.

Five of the 49 adult ALL patients analyzed (10%) showed loss of heterozygosity (LOH) or deletions at 13q14. Similar to CLL, the significant minimal deletions appeared to be localized between D13S260 and AFMa301wb5 and did not involve the retinoblastoma or BRCA2 genes. Among newly diagnosed patients, LOH was associated with shorter survival (P ϭ 0.007).

CONCLUSIONS. These data suggest that the 13q14 gene, commonly deleted in CLL patients, also is deleted in some patients with adult ALL. Although the number of the cases in the current study is small, 13q deletions in ALL patients may play a role in the clinical behavior of this disease.